Melissa A. Elafros
- Virology top 10%
- HIV Research and Treatment 8
- Infectious Diseases top 10%
- HIV/AIDS Research and Interventions 5
- Psychiatry and Mental health top 10%
- Epilepsy research and treatment 9
- Neurology top 10%
- Botulinum Toxin and Related Neurological Disorders 8
-
- Pain Mechanisms and Treatments 8
-
- Pharmacological Effects and Toxicity Studies 5
-
- Bacterial Infections and Vaccines 4
-
- Cardiac Arrhythmias and Treatments 4
- Co-authors
- Brian C. CallaghanEva L. FeldmanMasha G. SavelieffVijay ViswanathanDavid BennettGretchen L. BirbeckHenning AndersenEllen M.H. Mitchell
- Partner nations
- United StatesZambiaUnited Kingdom
In The Last Decade
Melissa A. Elafros
40 papers receiving 836 citations
Hit Papers
Peers
Comparison fields: 5 of 99
- Virology 44
- Infectious Diseases 161
- Psychiatry and Mental health 128
- Neurology 98
- Physiology 157
Countries citing papers authored by Melissa A. Elafros
This map shows the geographic impact of Melissa A. Elafros's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Melissa A. Elafros with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Melissa A. Elafros more than expected).
Fields of papers citing papers by Melissa A. Elafros
This network shows the impact of papers produced by Melissa A. Elafros. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Melissa A. Elafros. The network helps show where Melissa A. Elafros may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Melissa A. Elafros, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2024 | 4 | |
| 4 | 2024 | 27 | |
| 5 | 2024 | 2 | |
| 6 | 2024 | 1 | |
| 7 | 2023 | 2 | |
| 8 | Towards prevention of diabetic peripheral neuropathy: clinical presentation, pathogenesis, and new treatmentsbreakdown → | 2022 | 196 |
| 9 | 2022 | 16 | |
| 10 | 2022 | 25 | |
| 11 | 2021 | 3 | |
| 12 | A scoping review of health-related stigma outcomes for high-burden diseases in low- and middle-income countriesbreakdown → | 2019 | 197 |
| 13 | 2018 | 5 | |
| 14 | 2017 | 8 | |
| 15 | 2015 | 8 | |
| 16 | 2014 | 11 | |
| 17 | 2014 | 5 | |
| 18 | 2014 | 6 | |
| 19 | 2014 | 18 | |
| 20 | 2013 | 34 |
About Melissa A. Elafros
Melissa A. Elafros is a scholar working on Virology, Psychiatry and Mental health and Neurology, having authored 43 papers that have together received 850 indexed citations. Recurring topics across this work include Epilepsy research and treatment (9 papers), Botulinum Toxin and Related Neurological Disorders (8 papers), HIV Research and Treatment (8 papers), Pain Mechanisms and Treatments (8 papers), HIV/AIDS Research and Interventions (5 papers), Pharmacological Effects and Toxicity Studies (5 papers), Bacterial Infections and Vaccines (4 papers) and Cardiac Arrhythmias and Treatments (4 papers). The work is most often cited by research in Virology (44 citations), Infectious Diseases (161 citations) and Psychiatry and Mental health (128 citations). Melissa A. Elafros has collaborated with scholars based in United States, Zambia and United Kingdom. Frequent co-authors include Brian C. Callaghan, Eva L. Feldman, Masha G. Savelieff, Vijay Viswanathan, David Bennett, Gretchen L. Birbeck, Henning Andersen, Ellen M.H. Mitchell, Sara Causevic and Sarah M. Murray. Their work appears in journals such as Neurology, Diabetes and The Lancet Neurology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.